Surfactant Protein D Interacts with α2-Macroglobulin and Increases Its Innate Immune Potential

被引:23
|
作者
Craig-Barnes, Hayley A.
Doumouras, Barbara S.
Palaniyar, Nades [1 ]
机构
[1] Hosp Sick Children, Program Physiol & Expt Med, Lung Innate Immun Res Lab, Toronto, ON M5G 1X8, Canada
基金
加拿大健康研究院;
关键词
MANNOSE-BINDING LECTIN; CYSTIC-FIBROSIS; BACTERIAL LIPOPOLYSACCHARIDES; HUMAN ALPHA-2-MACROGLOBULIN; BRONCHOALVEOLAR LAVAGE; LUNG COLLECTINS; RECOGNITION; ALPHA; FLUID; LOCALIZATION;
D O I
10.1074/jbc.M110.108837
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Surfactant protein D (SP-D) is an innate immune collectin that recognizes microbes via its carbohydrate recognition domains, agglutinates bacteria, and forms immune complexes. During microbial infections, proteases, such as elastases, cleave the carbohydrate recognition domains and can inactivate the innate immune functions of SP-D. Host responses to counterbalance the reduction of SP-D-mediated innate immune response under these conditions are not clearly understood. We have unexpectedly identified that SP-D could interact with protein fractions containing ovomucin and ovomacroglobulin. Here, we show that SP-D interacts with human alpha(2)-macroglobulin (A2M), a protease inhibitor present in the lungs and serum. Using enzyme-linked immunosorbent assays, surface plasmon resonance, and carbohydrate competition assays, we show that SP-D interacts with A2M both in solid phase (K-D of 7.33 nM) and in solution via lectin-carbohydrate interactions under physiological calcium conditions. Bacterial agglutination assays further show that SP-D.A2M complexes increase the ability of SP-D to agglutinate bacteria. Western blot analyses show that SP-D, but not A2M, avidly binds bacteria. Interestingly, intact and activated A2M also protect SP-D against elastase-mediated degradation, and the cleaved A2M still interacts with SP-D and is able to enhance its agglutination abilities. We also found that SP-D and A2M can interact with each other in the airway-lining fluid. Therefore, we propose that SP-D utilizes a novel mechanism in which the collectin interacts with protease inhibitor A2M to decrease its degradation and to concurrently increase its innate immune function. These interactions particularly enhance bacterial agglutination and immune complex formation.
引用
收藏
页码:13461 / 13470
页数:10
相关论文
共 50 条
  • [1] α2-macroglobulin:: an evolutionarily conserved arm of the innate immune system
    Armstrong, PB
    Quigley, JP
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 1999, 23 (4-5): : 375 - 390
  • [2] α2-Macroglobulin is a potential facilitator of prion protein transformation
    Adler, Victor
    Davidowitz, Eliot
    Tamburi, Patricia
    Rojas, Pedro
    Grossman, Abraham
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2007, 14 (01): : 1 - 10
  • [3] Role of α2-macroglobulin in the immune responses of invertebrates
    Armstrong, P. B.
    ISJ-INVERTEBRATE SURVIVAL JOURNAL, 2010, 7 (02): : 165 - 180
  • [4] Nonproteolytic incorporation of protein ligands into human α2-macroglobulin:: Implications for the binding mechanism of α2-macroglobulin
    Gron, H
    Pizzo, SV
    BIOCHEMISTRY, 1998, 37 (17) : 6009 - 6014
  • [5] Interaction of placental protein 14 with α2-macroglobulin
    Riely, GJ
    Koo, PH
    Tykocinksi, ML
    FASEB JOURNAL, 1998, 12 (04): : A621 - A621
  • [6] Structure of a bacterial α2-macroglobulin reveals mimicry of eukaryotic innate immunity
    Steve G. Wong
    Andréa Dessen
    Nature Communications, 5
  • [7] Structure of a bacterial α2-macroglobulin reveals mimicry of eukaryotic innate immunity
    Wong, Steve G.
    Dessen, Andrea
    NATURE COMMUNICATIONS, 2014, 5
  • [8] The contribution of α2-macroglobulin thrombin to the endogenous thrombin potential
    Hemker, H. C.
    de Smedt, E.
    Al Dieri, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (03) : 513 - 513
  • [10] Surfactant protein D of the innate immune defense is negatively associated with obesity
    Holmskov, U
    Lyster, G
    Hjelmborg, J
    Leth-Larsen, R
    Moeller, V
    Fenger, M
    Soerensen, T
    Kyvik, K
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 125 - 125